URSA-QUALITY-IMACMB2: Immunizations for Adolescents (IMACMB2)
  • 17 Dec 2024
  • 1 Minute to read
  • Dark
    Light

URSA-QUALITY-IMACMB2: Immunizations for Adolescents (IMACMB2)

  • Dark
    Light

Article summary

Measure Description

The percentage of adolescents 13 years of age who had one dose of meningococcal vaccine, one tetanus, diphtheria toxoids and acellular pertussis (Tdap) vaccine, and have completed the human papillomavirus (HPV) vaccine series by their 13th birthday. Unadjusted Certified Measure ed0479af-7f8a-414d-ac23-9469cd58f8d6

Metadata

  • Measure Type: Rate Measure
  • Temporal Structure: Entity
  • Component Class: Normal-Form
  • Denominator Case Field: Patient ID, Output NCQA Payer Type Code
  • Target Direction: Up

Denominator Description

Adolescents who turn 13 years of age during the measurement year.

Numerator Description

Qualifying denominator patients with one dose of meningococcal vaccine, one tetanus, diphtheria toxoids and acellular pertussis (Tdap) vaccine, and have completed the human papillomavirus (HPV) vaccine series by their 13th birthday.

NCQA MY2024

HEDISĀ® is a registered trademark of the National Committee for Quality Assurance (NCQA).


Was this article helpful?